The Prostate Cancer Prevention Trial (PCPT) risk calculator, on the other hand, estimates the probability of detecting prostate cancer with a biopsy as a function of age, prior PSA, and other variables – with the probability of a cancer diagnosis increasing as PSA and age prior to biopsy rise (16–19). The gene discussed is KLK3; the disease is prostate cancer.